Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA
Petti, M.C.; Mandelli, F.
Seminars in Oncology 16(1 Suppl 2: 10-15
1989
ISSN/ISBN: 0093-7754 PMID: 2928804 Document Number: 339718
Document emailed within 1 workday
Related Documents
Mandelli, F.; Petti, M.C.; Ardia, A.; Di Pietro, N.; Di Raimondo, F.; Ganzina, F.; Falconi, E.; Geraci, E.; Ladogana, S.; Latagliata, R. 1991: A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA European Journal of Cancer 27(6): 750-755Zittoun, R.; Mandelli, F.; Willemze, R.; de Witte, T.; Tura, S.; Ferrini, P.R.; Stryckmans, P.; Gattringer, C.; Petti, M.C.; Solbu, G. 1992: Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase IIi trial (AML8 A). the EORTC Leukemia Cooperative Group and the GIMEMA Group Leukemia 6(Suppl 2): 114-115
Polli, E.E. 1978: Results of the therapy of acute leukemia. A cooperative trial by the Italian Association Against Leukemias Israel Journal of Medical Sciences 14(12): 1203-1211
Invernizzi, R.; Rosanda, C.; Basso, G.; Conter, V.; di Cataldo, A.; Fenu, S.; Forni, M.; Frappampina, V.; Granchi, D.; Locatelli, F. 1992: Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias" Haematologica 77(1): 30-34
Suciu, S.; Solbu, G.; Zittoun, R.; Hayat, M.; Willemze, R.; de Witte, T.; Mandelli, F. 1991: Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA Bone Marrow Transplantation 7(Suppl 2): 34
Fujita, H.; Ogawa, M.; Masaoka, T.; Yamada, K.; Kimura, K. 1992: A pharmacokinetic study of idarubicin hydrochloride, a new anthracycline anti-tumor drug, in patients with acute leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(6): 791-798
Ogawa, M.; Masaoka, T.; Yamada, K.; Kimura, K. 1993: Early phase Ii study of Idarubicin, a new anthracycline anticancer drug, in acute leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(7): 897-906
Masaoka, T.; Ogawa, M.; Yamada, K.; Kimura, K.; Ohhashi, Y. 1993: A late phase Ii comparative study of idarubicin + cytarabine and daunorubicin + cytarabine in adult patients with acute non-lymphocytic leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(13): 1995-2005
Pavlovsky, S. 1981: Argentinian Group for the Treatment of Acute Leukemia: our experience in the treatment of acute lymphoblastic leukemias Sangre 26(5b): 845-854
Michalová, K.; Musilová, J.; Zemanová, Z. 1990: Cytogenetic abnormalities in 532 patients with myeloid leukemias and myelodyplastic syndrome. the Czechoslovak MDS Cooperative Group Czechoslovak Medicine 13(4): 133-144
Rowe, J.M.; Andersen, J.W.; Cassileth, P.A.; Oken, M.M.; Bennett, J.M.; Wiernik, P.H. 1992: Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experience Leukemia 6(Suppl 4): 75-77
Carli, M.; Perilongo, G.; di Montezemolo, L.C.; De Bernardi, B.; Ceci, A.; Paolucci, G.; Pianca, C.; Calculli, G.; Di Tullio, M.T.; Grotto, P. 1987: Phase II trial of cisplatin and etoposide in children with advanced soft tissue sarcoma: a report from the Italian Cooperative Rhabdomyosarcoma Group Cancer Treatment Reports 71(5): 525-527
Locatelli, F.; Alberti, D.; Graziani, G.; Buccianti, G.; Redaelli, B.; Giangrande, A.; Marcelli, D.; Francucci, B.M. 1992: Factors affecting chronic renal failure progression: results from a multicentre trial. the Northern Italian Cooperative Study Group Mineral and Electrolyte Metabolism 18(2-5): 295-302
Rovelli, F. 1985: The Italian experience on the thrombolysis of myocardial infarct. Considerations on data from the Italian Group for the Testing of Streptokinase in Infarct Giornale Italiano di Cardiologia 15(12): 1117-1120
Sacchi, S.; Gugliotta, L.; Papineschi, F.; Liberati, A.M.; Rupoli, S.; Delfini, C.; Ruggeri, M.; Cavanna, L.; Bucalossi, A.; Benedetti, E.; Ferrandina, C.; Vinci, G.; Morselli, M.; Torelli, G. 1998: Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone. Italian Cooperative Group on ET Leukemia 12(3): 289-294
Cimino, G.; Rapanotti, M.C.; Biondi, A.; Elia, L.; Lo Coco, F.; Price, C.; Rossi, V.; Rivolta, A.; Canaani, E.; Croce, C.M.; Mandelli, F.; Greaves, M. 1997: Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias Cancer Research 57(14): 2879-2883
Fischerman, K.; Mouridsen, H.T. 1984: Danish Breast Cancer Cooperative Group (DBCG). Present status and experience Acta Chirurgica Scandinavica. Supplementum 519: 55-59
Sledge, G.W. 1996: Role of paclitaxel in the treatment of breast cancer: the American Cooperative Group Experience Seminars in Oncology 23(1 Suppl. 1): 10-12
Iannace, C.; Di Libero, L.; Manetta, F.; Sciascia, V.; Pizza, A.; Napolitano, S.; Ferraro, A.; Scetta, G.; Esposito, D.; Varriale, S.; Candela, G.; Caracciolo, F. 2009: Coleman lipofilling: experience of an Italian group and review of the literature Chirurgia Italiana 61(1): 67-75
Sledge, G.W.; Robert, N.; Sparano, J.A.; Cobeligh, M.; Goldstein, L.J.; Neuberg, D.; Rowinsky, E.; Baughman, C.; McCaskill-Stevens, W. 1994: Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience Seminars in Oncology 21(5 Suppl 8: 15-18